理肺消癌汤治疗中晚期肺癌的临床效果分析.docVIP

精品论文 参考文献 理肺消癌汤治疗中晚期肺癌的临床效果分析 湖南省张家界市中医院 427000 【摘 要】目的：研究理肺消癌汤治疗中晚期肺癌的临床效果。方法：选择我院2014年6月-2015年12月中晚期肺癌患者80例进行分组回顾分析。A组进行常规化疗，B组在A组基础上接受理肺消癌汤治疗。比较两组患者中晚期肺癌病情治疗客观有效率、稳定率；中位生存期、1年生存率；用药前和用药结束患者生存质量分数的差异。结果：B组相较于A组中晚期肺癌病情治疗客观有效率、稳定率更高，P＜0.05；B组相较于A组中位生存期更长、1年生存率更高，P＜0.05；用药前两组生存质量分数相似，P＞0.05；用药结束A组生存质量分数无显著改变，而B组生存质量分数显著优于用药前，P＜0.05。结论：理肺消癌汤治疗中晚期肺癌的临床效果确切，可有效改善患者临床症状，稳定瘤体，延长其生存时间，提高生存率，提升患者生存质量，值得推广。 【关键词】理肺消癌汤；中晚期肺癌；临床效果 【 abstract 】 objective：to study the reason of lung cancer to treat middle-late stage lung cancer clinical effect. Methods：our hospital on June 6，2014-December 2015 middle-late group，80 cases of lung cancer patients by retrospective analysis. Routine chemotherapy group A and group B on the basis of group A accept Richard lung cancer decoction. Compare two groups of patients with locally advanced lung cancer illness treatment objective effectiveness，stability factor；The median surial，1 year survival rate；The preparation before and end the patients quality of life scores differences. Results：in group B than in group A middle-late lung disease treatment objective effectiveness，the stability factor is higher，P lt; 0.05；Group B than in group A median survival period is longer，1 year survival rate is higher，P lt; 0.05；Quality of life scores similar drugs in the first two groups，P gt; 0.05；Drug use over A set of quality of life scores had no significant change，and the quality of life scores significantly better than group B before medication，P lt; 0.05. Conclusion：Richard lung cancer elimination soup treat middle-late stage lung cancer clinical effect is precise，which can effectively improve the patients clinical symptoms，stable tumors and prolong the survival time and improve the survival rate，improve patient quality of life，is worth promoting. 【 key words 】 Richard lung cancer soup；Middle-late stage lung cancer. Clinical effect 肺癌为临床常见恶性肿瘤，对人们身心健康造成严重危害，可威胁人们生命安全，降低生存质量。多数肺癌患者在确诊时已经处于中晚期，无法有效进行手术切除病灶治疗，多采取化疗治疗，但化疗毒副作用大，不利于患者生存质量的提升[1]。本研究对